Efficient megakaryopoiesis and platelet production require phospholipid remodeling and PUFA uptake through CD36. | Efficient megakaryopoiesis and platelet production require phospholipid remodeling and PUFA uptake through CD36. Barrachina MN, Pernes G, Becker IC, Allaeys I, Hirsch TI, Groeneveld DJ, Khan AO, Freire D, Guo K, Carminita E, Morgan PK, Collins TJC, Mellett NA, Wei Z, Almazni I, Italiano JE, Luyendyk J, Meikle PJ, Puder M, Morgan NV, Boilard E, Murphy AJ, Machlus KR. | 10/8/2024 |
A novel peptide encoded by circ-SLC9A6 promotes lipid dyshomeostasis through the regulation of H4K16ac-mediated CD36 transcription in NAFLD. | A novel peptide encoded by circ-SLC9A6 promotes lipid dyshomeostasis through the regulation of H4K16ac-mediated CD36 transcription in NAFLD. Wang Y, Tian X, Wang Z, Liu D, Zhao X, Sun X, Tu Z, Li Z, Zhao Y, Zheng S, Yao J., Free PMC Article | 09/13/2024 |
Age-related alteration of the involvement of CD36 for salivary secretion from the parotid gland in mice. | Age-related alteration of the involvement of CD36 for salivary secretion from the parotid gland in mice. Satoh K, Ohno Y, Nagase H, Kashimata M, Adachi K., Free PMC Article | 09/6/2024 |
Galectin-3 alleviates demyelination by modulating microglial anti-inflammatory polarization through PPARgamma-CD36 axis. | Galectin-3 alleviates demyelination by modulating microglial anti-inflammatory polarization through PPARγ-CD36 axis. Wang Q, Zeng F, Fang C, Sun Y, Zhao X, Rong X, Zhang H, Xu Y. | 08/30/2024 |
Role of CD36 in Palmitic Acid Lipotoxicity in Neuro-2a Neuroblastoma Cells. | Role of CD36 in Palmitic Acid Lipotoxicity in Neuro-2a Neuroblastoma Cells. Urso CJ, Zhou H., Free PMC Article | 07/29/2024 |
CD36 deletion prevents white matter injury by modulating microglia polarization through the Traf5-MAPK signal pathway. | CD36 deletion prevents white matter injury by modulating microglia polarization through the Traf5-MAPK signal pathway. Hou X, Qu X, Chen W, Sang X, Ye Y, Wang C, Guo Y, Shi H, Yang C, Zhu K, Zhang Y, Xu H, Lv L, Zhang D, Hou L., Free PMC Article | 06/13/2024 |
Visceral adipose of obese mice inhibits endothelial inwardly rectifying K[+] channels in a CD36-dependent fashion. | Visceral adipose of obese mice inhibits endothelial inwardly rectifying K(+) channels in a CD36-dependent fashion. Rokka S, Sadeghinejad M, Hudgins EC, Johnson EJ, Nguyen T, Fancher IS., Free PMC Article | 06/5/2024 |
Unveiling the hidden role of the interaction between CD36 and FcgammaRIIb: implications for autoimmune disorders. | Unveiling the hidden role of the interaction between CD36 and FcγRIIb: implications for autoimmune disorders. He C, Hua G, Liu Y, Li S., Free PMC Article | 05/24/2024 |
CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function. | CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function. Niu H, Ren X, Tan E, Wan X, Wang Y, Shi H, Hou Y, Wang L., Free PMC Article | 04/2/2024 |
RFX1 regulates foam cell formation and atherosclerosis by mediating CD36 expression. | RFX1 regulates foam cell formation and atherosclerosis by mediating CD36 expression. Yang S, Min X, Hu L, Zheng M, Lu S, Zhao M, Jia S. | 03/28/2024 |
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC. | Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC. Deng T, Zhao J, Tong Y, Chen Z, He B, Li J, Chen B, Li R, Deng L, Yu H, Zhang B, Zhang T, Shi Z, Gao B, Jiang J, Shan Y, Yu Z, Jin Y, Wang Y, Xia J, Chen G. | 03/26/2024 |
Early-life stress perturbs the epigenetics of Cd36 concurrent with adult onset of NAFLD in mice. | Early-life stress perturbs the epigenetics of Cd36 concurrent with adult onset of NAFLD in mice. Fu Q, Frick JM, O'Neil MF, Eller OC, Morris EM, Thyfault JP, Christianson JA, Lane RH., Free PMC Article | 03/21/2024 |
Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis. | Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis. Wang S, Han Y, Liu R, Hou M, Neumann D, Zhang J, Wang F, Li Y, Zhao X, Schianchi F, Dai C, Liu L, Nabben M, Glatz JFC, Wu X, Lu X, Li X, Luiken JJFP., Free PMC Article | 03/5/2024 |
CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway. | CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway. Liu H, Guo W, Wang T, Cao P, Zou T, Peng Y, Yan T, Liao C, Li Q, Duan Y, Han J, Zhang B, Chen Y, Zhao D, Yang X., Free PMC Article | 02/7/2024 |
The effects of intermittent hypoxia on hepatic expression of fatty acid translocase CD36 in lean and diet-induced obese mice. | The effects of intermittent hypoxia on hepatic expression of fatty acid translocase CD36 in lean and diet-induced obese mice. Ji Y, Liang Y, Chu PH, Ge M, Yeung SC, Ip MSM, Mak JCW., Free PMC Article | 11/6/2023 |
Cluster-determinant 36 (CD36) mediates intestinal absorption of dietary astaxanthin and affects its secretion. | Cluster-determinant 36 (CD36) mediates intestinal absorption of dietary astaxanthin and affects its secretion. Liu X, Zhang J, Chen Z, Xiao J, Zhou A, Fu Y, Cao Y. | 10/10/2023 |
LncRNA AK142643 promotes hepatic lipid accumulation by upregulating CD36 via interacting with IGF2BP2. | LncRNA AK142643 promotes hepatic lipid accumulation by upregulating CD36 via interacting with IGF2BP2. Wang P, Wang X, He D, Zhuang C. | 09/28/2023 |
Endothelial cell CD36 regulates membrane ceramide formation, exosome fatty acid transfer and circulating fatty acid levels. | Endothelial cell CD36 regulates membrane ceramide formation, exosome fatty acid transfer and circulating fatty acid levels. Peche VS, Pietka TA, Jacome-Sosa M, Samovski D, Palacios H, Chatterjee-Basu G, Dudley AC, Beatty W, Meyer GA, Goldberg IJ, Abumrad NA., Free PMC Article | 09/6/2023 |
Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment. | Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment. Meng Y, Pospiech M, Ali A, Chandwani R, Vergel M, Onyemaechi S, Yaghmour G, Lu R, Alachkar H., Free PMC Article | 08/23/2023 |
ATF4-mediated CD36 upregulation contributes to palmitate-induced lipotoxicity in hepatocytes. | ATF4-mediated CD36 upregulation contributes to palmitate-induced lipotoxicity in hepatocytes. Griffiths A, Wang J, Song Q, Lee SM, Cordoba-Chacon J, Song Z., Free PMC Article | 08/11/2023 |
Hepatocyte CD36 modulates UBQLN1-mediated proteasomal degradation of autophagic SNARE proteins contributing to septic liver injury. | Hepatocyte CD36 modulates UBQLN1-mediated proteasomal degradation of autophagic SNARE proteins contributing to septic liver injury. Li Y, Xu J, Chen W, Wang X, Zhao Z, Li Y, Zhang L, Jiao J, Yang Q, Ding Q, Yang P, Wei L, Chen Y, Chen Y, Ruan XZ, Zhao L., Free PMC Article | 08/3/2023 |
Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR-CD36 axis. | Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR-CD36 axis. Liu J, Zhang X, Zhang Y, Qian M, Yang M, Yang S, Wang L. | 06/22/2023 |
Fibrin-glycoprotein VI interaction increases platelet procoagulant activity and impacts clot structure. | Fibrin-glycoprotein VI interaction increases platelet procoagulant activity and impacts clot structure. Gauer JS, Duval C, Xu RG, Macrae FL, McPherson HR, Tiede C, Tomlinson D, Watson SP, Ariëns RAS. | 03/8/2023 |
A CD36 transmembrane domain peptide interrupts CD36 interactions with membrane partners on macrophages and inhibits atherogenic functions. | A CD36 transmembrane domain peptide interrupts CD36 interactions with membrane partners on macrophages and inhibits atherogenic functions. Huang W, Li R, Zhang J, Cheng Y, Ramakrishnan DP, Silverstein RL., Free PMC Article | 03/6/2023 |
Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice. | Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice. Devereux CJ, Bayliss J, Keenan SN, Montgomery MK, Watt MJ. | 02/15/2023 |